JPMorgan Chase & Co. Has Lowered Expectations for UnitedHealth Group (NYSE:UNH) Stock Price

UnitedHealth Group (NYSE:UNH - Free Report) had its price target cut by JPMorgan Chase & Co. from $652.00 to $525.00 in a research report report published on Thursday,Benzinga reports. They currently have an overweight rating on the healthcare conglomerate's stock.

A number of other research analysts have also recently weighed in on UNH. HSBC restated a "hold" rating and issued a $490.00 price objective on shares of UnitedHealth Group in a report on Tuesday, April 22nd. Argus lowered UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Cantor Fitzgerald reiterated an "overweight" rating and issued a $700.00 price objective on shares of UnitedHealth Group in a research note on Friday, January 17th. Truist Financial reduced their target price on shares of UnitedHealth Group from $660.00 to $580.00 and set a "buy" rating on the stock in a report on Monday, April 21st. Finally, Royal Bank of Canada dropped their price objective on shares of UnitedHealth Group from $655.00 to $525.00 and set an "outperform" rating on the stock in a research report on Wednesday, April 23rd. Three analysts have rated the stock with a hold rating, nineteen have issued a buy rating and three have given a strong buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Buy" and an average price target of $603.05.

UnitedHealth Group Trading Up 0.3 %

Shares of UnitedHealth Group stock traded up $1.40 during trading hours on Thursday, hitting $420.04. The company's stock had a trading volume of 6,597,832 shares, compared to its average volume of 4,490,671. The stock has a market cap of $382.33 billion, a price-to-earnings ratio of 27.10, a P/E/G ratio of 1.37 and a beta of 0.61. UnitedHealth Group has a twelve month low of $412.02 and a twelve month high of $630.73. The firm has a fifty day moving average of $503.28 and a 200-day moving average of $534.18. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 EPS for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $109.58 billion during the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the prior year, the company posted $6.91 earnings per share. Research analysts forecast that UnitedHealth Group will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Monday, March 10th were issued a dividend of $2.10 per share. This represents a $8.40 dividend on an annualized basis and a yield of 2.00%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group's dividend payout ratio is presently 35.18%.

Hedge Funds Weigh In On UnitedHealth Group

A number of large investors have recently made changes to their positions in the stock. D.A. Davidson & CO. lifted its position in shares of UnitedHealth Group by 1.7% during the 1st quarter. D.A. Davidson & CO. now owns 42,486 shares of the healthcare conglomerate's stock valued at $22,252,000 after acquiring an additional 695 shares during the period. Rosenberg Matthew Hamilton raised its holdings in UnitedHealth Group by 3.5% during the first quarter. Rosenberg Matthew Hamilton now owns 1,366 shares of the healthcare conglomerate's stock worth $716,000 after purchasing an additional 46 shares during the last quarter. MBM Wealth Consultants LLC grew its holdings in UnitedHealth Group by 1.9% in the first quarter. MBM Wealth Consultants LLC now owns 2,926 shares of the healthcare conglomerate's stock valued at $1,532,000 after purchasing an additional 54 shares during the last quarter. Smart Money Group LLC acquired a new position in shares of UnitedHealth Group during the 1st quarter worth $200,000. Finally, Resonant Capital Advisors LLC grew its stake in UnitedHealth Group by 13.9% in the 1st quarter. Resonant Capital Advisors LLC now owns 2,995 shares of the healthcare conglomerate's stock valued at $1,569,000 after acquiring an additional 365 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.